Tonix Pharmaceuticals (NASDAQ:TNXP) announced on Monday an addition to the broad-market Russell 3000 Index and an automatic inclusion in the small-cap Russell 2000 Index.
Shares were +0.32% pre-market to $35.00.
The addition, effective after the market open on June 30, is a part of the 2025 Russell indexes reconstitution.